Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1996-9-10
pubmed:abstractText
To describe the postoperative course of patients who underwent hyperthermic isolated limb perfusion with recombinant tumor necrosis factor (TNF)-alpha and melphalan after pretreatment with recombinant interferon-gamma as treatment for recurrent melanoma, primary nonresectable soft-tissue tumors, planocellular carcinoma, or metastatic carcinoma. To measure systemic TNF-alpha concentrations and relate these values with indices of disease severity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0090-3493
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
765-70
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:8706451-Adolescent, pubmed-meshheading:8706451-Adult, pubmed-meshheading:8706451-Aged, pubmed-meshheading:8706451-Antineoplastic Agents, Alkylating, pubmed-meshheading:8706451-Chemotherapy, Cancer, Regional Perfusion, pubmed-meshheading:8706451-Combined Modality Therapy, pubmed-meshheading:8706451-Extremities, pubmed-meshheading:8706451-Female, pubmed-meshheading:8706451-Hemodynamics, pubmed-meshheading:8706451-Humans, pubmed-meshheading:8706451-Hyperthermia, Induced, pubmed-meshheading:8706451-Interferon-gamma, pubmed-meshheading:8706451-Linear Models, pubmed-meshheading:8706451-Male, pubmed-meshheading:8706451-Melphalan, pubmed-meshheading:8706451-Middle Aged, pubmed-meshheading:8706451-Neoplasms, pubmed-meshheading:8706451-Prospective Studies, pubmed-meshheading:8706451-Recombinant Proteins, pubmed-meshheading:8706451-Severity of Illness Index, pubmed-meshheading:8706451-Systemic Inflammatory Response Syndrome, pubmed-meshheading:8706451-Tumor Necrosis Factor-alpha
pubmed:year
1996
pubmed:articleTitle
High plasma tumor necrosis factor (TNF)-alpha concentrations and a sepsis-like syndrome in patients undergoing hyperthermic isolated limb perfusion with recombinant TNF-alpha, interferon-gamma, and melphalan.
pubmed:affiliation
Department of Anesthesia, Royal Victoria Infirmary, Newcastle on Tyne, UK.
pubmed:publicationType
Journal Article, Clinical Trial